| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |